SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-008244
Filing Date
2011-02-14
Accepted
2011-02-14 14:12:50
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q v211017_10q.htm 10-Q 1768609
2 GRAPHIC chart.jpg GRAPHIC 39046
3 EX-31.1 v211017_ex31-1.htm EX-31.1 11986
4 EX-31.2 v211017_ex31-2.htm EX-31.2 12382
5 EX-32.1 v211017_ex32-1.htm EX-32.1 6800
6 EX-32.2 v211017_ex32-2.htm EX-32.2 7221
  Complete submission text file 0001144204-11-008244.txt   1862587
Mailing Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD, ZHIFU DISTRICT YANTAI, SHANDONG PROVINCE F4 264000
Business Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD, ZHIFU DISTRICT YANTAI, SHANDONG PROVINCE F4 264000 86-535-6763559
Bohai Pharmaceuticals Group, Inc. (Filer) CIK: 0001443242 (see all company filings)

IRS No.: 980588402 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53401 | Film No.: 11605743
SIC: 2834 Pharmaceutical Preparations